Covid-19 roundup: CDC rec­om­mends mR­NA vac­cines over J&J’s due to rare blood clots; EU con­sid­ers deal for vari­ant-spe­cif­ic dos­es of Pfiz­er/BioN­Tech vac­cine

The CDC has of­fi­cial­ly rec­om­mend­ed that Amer­i­cans re­ceive one of the mR­NA vac­cines over J&J’s sin­gle-dose vac­cine due to re­newed con­cerns about rare but some­times fa­tal blood clots.

The de­ci­sion fol­lowed a unan­i­mous vote by the Ad­vi­so­ry Com­mit­tee on Im­mu­niza­tion Prac­tices (ACIP) to rec­om­mend against tak­ing J&J’s shot, if ei­ther the Pfiz­er/BioN­Tech or Mod­er­na shot is avail­able. J&J’s vac­cine will still be avail­able to those who are un­able or un­will­ing to get an mR­NA vac­cine.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.